Metrics as of 10/13/2026, 06:38 PM (Berlin time), refresh in progress.
NeuroOne Medical Technologies Stock
NeuroOne Medical Technologies Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- David A. Rosa
- Employees
- 18
- Market cap
- $9 M
- IPO
- 15/03/2018
- Web
- nmtc1.com
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of…
NeuroOne Medical Technologies stock: price history
1D
-7.6%
1W
-14.2%
1M
-31.8%
6M
-80.1%
YTD
-78.9%
1Y
-81.4%
2Y
-82.8%
5Y
-94.7%
10Y
–
Next earnings date
Next earnings date
15/12/2026 (in 59 days)
Volatility around earnings
~7% stronger price swings than usual
Ask the agents about NeuroOne Medical Technologies
Analyst assessment of NeuroOne Medical Technologies
PRICE TARGET LOW
US$5.00
CONSENSUS
US$5.00
MEDIAN
US$5.00
PRICE TARGET HIGH
US$5.00
0
STRONG BUY
3
BUY
1
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 14/08/2026
NeuroOne Medical Technologies stock metrics
P/E
-1.05
P/B
2.21
EV/EBITDA
-0.98
RETURN ON EQUITY
-53.3%
NET MARGIN
-101.7%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
79.6%
FLOAT SHARES
7,249,232
AVG. DAILY VOLUME (30D)
165,457
Insider transactions (SEC)
Wambeke David J.
Christianson Mark
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about NeuroOne Medical Technologies stock
What does NeuroOne Medical Technologies do?
NeuroOne Medical Technologies Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is David A. Rosa, the company employs around 18 people.
The IPO was on 15/03/2018; the stock trades on NASDAQ under the ticker NMTC.
What do analysts say about NeuroOne Medical Technologies stock?
4 analysts rate the stock, the consensus is Buy (as of 14/08/2026).
The average price target is US$5.00, ranging from US$5.00 to US$5.00, with a median of US$5.00.
This is an external assessment, not a statement by Market Jury.
When does NeuroOne Medical Technologies report next?
The next earnings date is 15/12/2026.
Around past earnings, price swings were roughly 7% stronger than usual.
Does NeuroOne Medical Technologies pay a dividend?
No, NeuroOne Medical Technologies currently does not pay a dividend.
Which stocks are comparable to NeuroOne Medical Technologies?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get NeuroOne Medical Technologies stock analyzed?
Clicking "Analyze stock" lets five strategies assess NeuroOne Medical Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.